Study on Aging, Menopause, and Blood Vessel Responses to Low Oxygen
This study aims to understand how aging and menopause affect how your blood vessels respond to low oxygen levels (hypoxia). Researchers are looking at women who are pre-menopausal, peri-menopausal (around menopause), or post-menopausal. You might receive a placebo (an inactive pill), Propranolol (1 mg/kg), or Gemtesa (75 mg). The main goal is to measure changes in blood flow in your forearm after 5 minutes. To join, you must be a woman between 18 and 70 years old, with a healthy weight (BMI between 18 and 30). This study is currently recruiting participants.
- Study design
- This is an interventional study planning to enroll 75 women. Participants will receive either a placebo, Propranolol, or Gemtesa.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, forearm blood flow, is measured at 5 minutes after baseline.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Forearm blood flowChange from baseline to 5 minutes.
Blood flow in the forearm measured with venous occlusion plethysmography.